Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: Relationship to apoptosis

Human Reproduction

Volumn 15, Issue 9, 2000, Pages 1889-1897

  Cataldo, Nicholas A ^a,d   Dumesic, Daniel A ^b   Goldsmith, Paul C ^a,c   Jaffe, Robert B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Fas; Fas ligand; Human ovary; Polycystic ovary syndrome

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0033811055     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.9.1889     Document Type: Article

References (43)

1. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
2. Functional integrity of granulosa cells from polycystic ovaries
3. Effect of gonadotropins, insulin and IGF I on granulosa luteal cells from polycystic ovaries
4. Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome
5. Human luteinizing granulosa cells express APO-1/Fas, and interferon-gamma increases their susceptibility to anti-APO-1-mediated apoptosis
6. Growth factors in ovarian follicle atresia
7. IAP family proteins - Suppressors of apoptosis
8. New data on follicle cells in polycystic ovaries: A proposed mechanism for the genesis of cystic follicles
9. Granulosa cells of polycystic ovaries: Are they normal of abnormal?
10. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway
11. Etiology of anovulation in polycystic ovary syndrome
12. Dynamics of human follicular growth: A morphologic perspective
13. Ovarian morphology in oligomenorrhea
14. Fas ligand-induced apoptosis as a mechanism of immune privilege
15. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
16. Polycystic ovary syndrome - Loss of the apoptotic mechanism in the ovarian follicles?
17. Ovarian follicle atresia: A hormonally controlled apoptotic process
18. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called 'hyperthecosis'
19. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
20. Granulosa cell apoptosis induced at the penultimate stage of follicular development is associated with increased levels of Fas and Fas ligand in the rat ovary
21. Immunological evidence for the expression of the Fas antigen in the infant and adult human ovary during follicular regression and atresia
22. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
23. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
24. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia
25. Neuronal apoptosis inhibitory protein (NAIP) may enhance the survival of granulosa cells thus indirectly affecting oocyte survival
26. The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro
27. Follicular development during the luteal phase of the human menstrual cycle
28. Ovulation induction in polycystic ovary syndrome: A review of conservative and new treatment modalities
29. Expression of Fas-Fas ligand system associated with atresia through apoptosis in murine ovary
30. The Fas death factor
31. Expression and function of Fas antigen vary in bovine granulosa and theca cells during ovarian follicular development and atresia
32. Fas antigen-mediated apoptosis in human granulosa/luteal cells
33. Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis
34. Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival
35. Involvement of Fas antigen in ovarian follicular atresia and luteolysis
36. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy
37. VEGF production by the human ovary
38. Monoclonal antibody-mediated tumor regression by induction of apoptosis
39. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients
40. Expression and activity of the Fas antigen in bovine ovarian follicle cells
41. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-1pr/lpr murine ovary
42. Programmed cell death in human ovary is a function of follicle and corpus luteum status
43. Ovarian stromal blood flow in women with polycystic ovaries - A possible new marker for diagnosis?